Company Filing History:
Years Active: 2013-2024
Title: Matthias Dreyer: Innovator in Biopharmaceuticals
Introduction
Matthias Dreyer is a prominent inventor based in Frankfurt-am-Main, Germany. With a total of four patents to his name, he has made significant contributions to the field of biopharmaceuticals, particularly in innovative therapeutic agents for various metabolic conditions.
Latest Patents
Dreyer's latest patents include groundbreaking inventions such as FGFR1/KLB targeting agonistic antigen-binding proteins, which are designed to enhance treatment efficacy in targeted therapies. This technology involves novel antigen-binding proteins that exhibit improved physico-chemical properties, offering the potential for effective medicinal applications. Additionally, he has developed pharmaceutical compositions that include conjugates of these proteins with GLP-1R agonistic peptides.
Another notable invention by Dreyer pertains to polypeptide variants of human fibroblast growth factor 21 (FGF21) and related nucleic acid molecules. These innovations hold promise in treating various health issues, including obesity, metabolic syndrome, and diabetes mellitus, making substantial strides in the realm of metabolic therapy.
Career Highlights
Matthias Dreyer currently works at Sanofi, a leading global biopharmaceutical company renowned for its innovation in the healthcare field. His work has greatly contributed to advancing medical science and improving patient outcomes through innovative treatment methodologies.
Collaborations
Throughout his career, Dreyer has collaborated with esteemed colleagues such as Oliver Plettenburg and Armin Hofmeister. Their joint efforts in research and development have facilitated the creation of effective therapeutic solutions aimed at addressing complex healthcare challenges.
Conclusion
With four patents and continuous efforts towards innovation, Matthias Dreyer exemplifies the spirit of ingenuity in the life sciences sector. His work at Sanofi and collaborations with fellow researchers underscore the importance of teamwork in achieving groundbreaking advancements in medicine. Dreyer's contributions are paving the way for novel treatments that can significantly impact patients' lives globally.